108 related articles for article (PubMed ID: 19010295)
1. Efficacy of tetrathiomolybdate in a mouse model of multiple sclerosis.
Hou G; Abrams GD; Dick R; Brewer GJ
Transl Res; 2008 Nov; 152(5):239-44. PubMed ID: 19010295
[TBL] [Abstract][Full Text] [Related]
2. Comparison of lowering copper levels with tetrathiomolybdate and zinc on mouse tumor and doxorubicin models.
Hou G; Dick R; Zeng C; Brewer GJ
Transl Res; 2006 Dec; 148(6):309-14. PubMed ID: 17162252
[TBL] [Abstract][Full Text] [Related]
3. The use of tetrathiomolybdate in treating fibrotic, inflammatory, and autoimmune diseases, including the non-obese diabetic mouse model.
Brewer GJ; Dick R; Zeng C; Hou G
J Inorg Biochem; 2006 May; 100(5-6):927-30. PubMed ID: 16321443
[TBL] [Abstract][Full Text] [Related]
4. Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study.
Brewer GJ; Dick RD; Grover DK; LeClaire V; Tseng M; Wicha M; Pienta K; Redman BG; Jahan T; Sondak VK; Strawderman M; LeCarpentier G; Merajver SD
Clin Cancer Res; 2000 Jan; 6(1):1-10. PubMed ID: 10656425
[TBL] [Abstract][Full Text] [Related]
5. Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice.
Brewer GJ; Ullenbruch MR; Dick R; Olivarez L; Phan SH
J Lab Clin Med; 2003 Mar; 141(3):210-6. PubMed ID: 12624602
[TBL] [Abstract][Full Text] [Related]
6. Tetrathiomolybdate is effective in a mouse model of arthritis.
McCubbin MD; Hou G; Abrams GD; Dick R; Zhang Z; Brewer GJ
J Rheumatol; 2006 Dec; 33(12):2501-6. PubMed ID: 17143984
[TBL] [Abstract][Full Text] [Related]
7. Antitumor and antiinflammatory effects of tetrathiotungstate in comparison with tetrathiomolybdate.
Hou G; Dick R; Zeng C; Brewer GJ
Transl Res; 2007 May; 149(5):260-4. PubMed ID: 17466925
[TBL] [Abstract][Full Text] [Related]
8. Improvement in dissolution of liver fibrosis in an animal model by tetrathiomolybdate.
Hou G; Dick R; Brewer GJ
Exp Biol Med (Maywood); 2009 Jun; 234(6):662-5. PubMed ID: 19307461
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of key cytokines by tetrathiomolybdate in the bleomycin model of pulmonary fibrosis.
Brewer GJ; Dick R; Ullenbruch MR; Jin H; Phan SH
J Inorg Biochem; 2004 Dec; 98(12):2160-7. PubMed ID: 15541506
[TBL] [Abstract][Full Text] [Related]
10. Tetrathiomolybdate is partially protective against hyperglycemia in rodent models of diabetes.
Zeng C; Hou G; Dick R; Brewer GJ
Exp Biol Med (Maywood); 2008 Aug; 233(8):1021-5. PubMed ID: 18480419
[TBL] [Abstract][Full Text] [Related]
11. Anticopper therapy against cancer and diseases of inflammation and fibrosis.
Brewer GJ
Drug Discov Today; 2005 Aug; 10(16):1103-9. PubMed ID: 16182195
[TBL] [Abstract][Full Text] [Related]
12. Cancer therapy with tetrathiomolybdate: antiangiogenesis by lowering body copper--a review.
Brewer GJ; Merajver SD
Integr Cancer Ther; 2002 Dec; 1(4):327-37. PubMed ID: 14664727
[TBL] [Abstract][Full Text] [Related]
13. The translation of drug efficacy from in vivo models to human disease with special reference to experimental autoimmune encephalomyelitis and multiple sclerosis.
Bolton C
Inflammopharmacology; 2007 Oct; 15(5):183-7. PubMed ID: 17943249
[TBL] [Abstract][Full Text] [Related]
14. Tetrathiomolybdate, a copper chelator inhibited imiquimod-induced skin inflammation in mice.
Hsu PY; Yen HH; Yang TH; Su CC
J Dermatol Sci; 2018 Oct; 92(1):30-37. PubMed ID: 30126748
[TBL] [Abstract][Full Text] [Related]
15. Tetrathiomolybdate protects against cardiac damage by doxorubicin in mice.
Hou G; Dick R; Abrams GD; Brewer GJ
J Lab Clin Med; 2005 Nov; 146(5):299-303. PubMed ID: 16242529
[TBL] [Abstract][Full Text] [Related]
16. Indolin-2-ones with high in vivo efficacy in a model for multiple sclerosis.
Bouérat L; Fensholdt J; Liang X; Havez S; Nielsen SF; Hansen JR; Bolvig S; Andersson C
J Med Chem; 2005 Aug; 48(17):5412-4. PubMed ID: 16107139
[TBL] [Abstract][Full Text] [Related]
17. The use of copper-lowering therapy with tetrathiomolybdate in medicine.
Brewer GJ
Expert Opin Investig Drugs; 2009 Jan; 18(1):89-97. PubMed ID: 19053885
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.
Reichardt HM; Gold R; Lühder F
Expert Rev Neurother; 2006 Nov; 6(11):1657-70. PubMed ID: 17144780
[TBL] [Abstract][Full Text] [Related]
19. The role of neurotrophic factors in the pathology and treatment of multiple sclerosis.
Mirowska-Guzel D
Immunopharmacol Immunotoxicol; 2009; 31(1):32-8. PubMed ID: 18792835
[TBL] [Abstract][Full Text] [Related]
20. Copper chelation with tetrathiomolybdate suppresses adjuvant-induced arthritis and inflammation-associated cachexia in rats.
Omoto A; Kawahito Y; Prudovsky I; Tubouchi Y; Kimura M; Ishino H; Wada M; Yoshida M; Kohno M; Yoshimura R; Yoshikawa T; Sano H
Arthritis Res Ther; 2005; 7(6):R1174-82. PubMed ID: 16277669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
